Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Big Money For Big Goals Met By Reata, CRISPR, Karuna

Nov 26 2019

• By Mandy Jackson

Finance Watch

Related Content

CRISPR Therapeutics, Vertex Initiate First Industry-Sponsored Trial – What’s Next?

Sep 06 2018

Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?

Jun 28 2018

Verastem’s Copiktra Gets Early Approval To Challenge Zydelig, Venclexta In Third-Line CLL

Sep 25 2018

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Aug 01 2018

Sierra Believes It Can Do Better Than Gilead With JAK Inhibitor Momelotinib

Aug 24 2018

Keeping Track Of Review Designations: BTDs For X4, F2G, And BMS; Another QIDP For Allergan

Nov 17 2019

FDA Approval Round Up: Keytruda, Opdivo Add Claims

Sep 25 2017

BioNTech, Neon Take A Step Forward In Personalized Cancer Vaccines

Jul 06 2017

IPO Update: Will Declining Returns Slow Fast Pace Of Biopharma Offerings?

Apr 03 2018

Karuna Upbeat On New Antipsychotic Mechanism Data

Nov 19 2019

Teva Turnaround Hung Up By The Uncertain Cost Of Settling Opioid Cases

Nov 07 2019

Halozyme’s Spotlight Shifts To Enhanze Exclusively After PEGPH20 Fails In Phase III

Nov 04 2019

Pipeline Watch: Phase III Readouts For Ibrexafungerp, Reloxaliase

Nov 11 2019

Pipeline Watch: Lumasiran, Empagliflozin Major Clinical Trial Starts

Nov 18 2019

Reata's Bardoxolone Promises Renal Benefits In Alport Syndrome

Nov 12 2019

Kiadis Crushed By EMA Rejection Of T-Cell Therapy

Oct 18 2019

Mixed Responses To BioCryst's Oral Phase III HAI Therapy, BCX7353

May 22 2019

Vadadustat Emerges As Japan HIF-PHI Contender With First Filing Globally

Jul 24 2019

IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

Oct 03 2019

Finance Watch: Two New IPOs – IGM In the US, Henlius In Hong Kong – Gross Nearly $600m

Sep 19 2019

Keeping Track: Thumbs Up For Zulresso And Sunosi, Thumbs Down For Zynquista And IV Meloxicam

Mar 24 2019

Related Companies

Reata Pharmaceuticals, Inc.

CRISPR Therapeutics AG

Karuna Therapeutics, Inc.

AbbVie Inc.

Vertex Pharmaceuticals Incorporated

Teva Pharmaceutical Industries Ltd.

NextCure, Inc.

Sierra Oncology, Inc.

Gilead Sciences, Inc.

Akebia Therapeutics, Inc.

Mitsubishi Tanabe Pharma Corporation

Replimune Group Inc.

Bristol Myers Squibb Company

Verastem, Inc.

BioCryst Pharmaceuticals, Inc.

OptiNose, Inc.

Societal CDMO, Inc.

Neon Therapeutics, Inc.

Kiadis Pharma N.V.

Cogent Biosciences, Inc.

Seagen Inc.

Additional Topics

Financing Business Strategies Clinical Trials Innovation Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window